These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 30853081)

  • 41. Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial.
    Chen L; Hu CS; Chen XZ; Hu GQ; Cheng ZB; Sun Y; Li WX; Chen YY; Xie FY; Liang SB; Chen Y; Xu TT; Li B; Long GX; Wang SY; Zheng BM; Guo Y; Sun Y; Mao YP; Tang LL; Chen YM; Liu MZ; Ma J
    Eur J Cancer; 2017 Apr; 75():150-158. PubMed ID: 28235726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different risks of symptomatic brain necrosis in NPC patients treated with different altered fractionated radiotherapy techniques.
    Jen YM; Hsu WL; Chen CY; Hwang JM; Chang LP; Lin YS; Su WF; Chen CM; Liu DW; Chao HL
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):344-8. PubMed ID: 11567807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus volumetric modulated arc therapy alone in the treatment of stage II-IVB nasopharyngeal carcinoma patients: a retrospective controlled study.
    Liu L; Fei Z; Chen M; Zhao L; Su H; Gu D; Lin B; Cai X; Lu L; Gao M; Ye X; Jin X; Xie C
    Radiat Oncol; 2018 Aug; 13(1):148. PubMed ID: 30103765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SMART (simultaneous modulated accelerated radiotherapy) for locally advanced nasopharyngeal carcinomas.
    Koom WS; Kim TH; Shin KH; Pyo HR; Kim JY; Kim DY; Yoon M; Park SY; Lee DH; Ryu JS; Jung YS; Lee SH; Cho KH
    Head Neck; 2008 Feb; 30(2):159-69. PubMed ID: 17764088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
    Zheng Y; Han F; Xiao W; Xiang Y; Lu L; Deng X; Cui N; Zhao C
    Radiat Oncol; 2015 Jan; 10():17. PubMed ID: 25582731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of radiotherapy combined with adjuvant chemotherapy in the treatment of patients with advanced nasopharyngeal carcinoma: a prospective study.
    Kong F; Cai B; Lin S; Zhang J; Wang Y; Fu Q
    J BUON; 2015; 20(1):206-11. PubMed ID: 25778317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome and long-term efficacy of four facio-cervical fields conformal radiotherapy for nasopharyngeal carcinoma.
    Fangzheng W; Chuner J; Lei W; Weijun C; Min X; Quanquan S; Tongxin L; Aizawa R; Sakamoto M; Zhenfu F
    Oncotarget; 2017 Jun; 8(24):39756-39765. PubMed ID: 28055973
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRT.
    Louis CU; Paulino AC; Gottschalk S; Bertuch AA; Chintagumpala M; Heslop HE; Russell HV
    J Pediatr Hematol Oncol; 2007 Jul; 29(7):500-5. PubMed ID: 17609631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term survival of nasopharyngeal carcinoma patients with Stage II in intensity-modulated radiation therapy era.
    Guo Q; Lu T; Lin S; Zong J; Chen Z; Cui X; Zhang Y; Pan J
    Jpn J Clin Oncol; 2016 Mar; 46(3):241-7. PubMed ID: 26755831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma.
    Peng G; Wang T; Yang KY; Zhang S; Zhang T; Li Q; Han J; Wu G
    Radiother Oncol; 2012 Sep; 104(3):286-93. PubMed ID: 22995588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of late toxicities on quality of life for survivors of nasopharyngeal carcinoma.
    Tsai WL; Huang TL; Liao KC; Chuang HC; Lin YT; Lee TF; Huang HY; Fang FM
    BMC Cancer; 2014 Nov; 14():856. PubMed ID: 25413127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lobaplatin combined with docetaxel neoadjuvant chemotherapy followed by concurrent lobaplatin with intensity-modulated radiotherapy increases the survival of patients with high-risk lymph node positive nasopharyngeal carcinoma.
    Zhang S; Lin S; Hu L
    J BUON; 2016; 21(1):161-7. PubMed ID: 27061544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.
    Kong L; Zhang Y; Hu C; Guo Y; Lu JJ
    Cancer; 2017 Jun; 123(12):2258-2267. PubMed ID: 28192641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.
    Yang H; Chen X; Lin S; Rong J; Yang M; Wen Q; Shang C; He L; Ren P; Xu S; Zhang J; Liu Q; Pang H; Shi X; Fan J; Sun X; Ma D; Tan B; Zhang T; Zhang L; Hu D; Du X; Zhang Y; Wen S; Zhang X; Wu J
    Radiother Oncol; 2018 Jan; 126(1):37-42. PubMed ID: 28864073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma.
    Qiu S; Lin S; Tham IW; Pan J; Lu J; Lu JJ
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):676-83. PubMed ID: 22024207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concurrent chemoradiotherapy was associated with a higher severe late toxicity rate in nasopharyngeal carcinoma patients compared with radiotherapy alone: a meta-analysis based on randomized controlled trials.
    Du CR; Ying HM; Kong FF; Zhai RP; Hu CS
    Radiat Oncol; 2015 Mar; 10():70. PubMed ID: 25889937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma.
    Guan Y; Liu S; Wang HY; Guo Y; Xiao WW; Chen CY; Zhao C; Lu TX; Han F
    Chin J Cancer; 2016 Feb; 35():20. PubMed ID: 26879049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A phase III randomized study comparing neoadjuvant chemotherapy with concurrent chemotherapy combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma: updated long-term survival outcomes.
    Xu T; Zhu G; He X; Ying H; Hu C
    Oral Oncol; 2014 Feb; 50(2):71-6. PubMed ID: 24315404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiotherapy combined docetaxel and oxaliplatin chemotherapy is effective in patients with locally advanced nasopharyngeal carcinoma.
    Pan F; Ruan Z; Li J; Pang X; Zhang Y; Zou L; Liang H
    Med Oncol; 2015 Nov; 32(11):252. PubMed ID: 26471179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical observation of 73 nasopharyngeal carcinoma patients treated by helical tomotherapy: the China experience.
    Ren G; Du L; Ma L; Feng LC; Zhou GX; Qu BL; Xu SP; Xie CB; Ou GM; Li F; Zhang XX; Yang J
    Technol Cancer Res Treat; 2011 Jun; 10(3):259-66. PubMed ID: 21517132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.